Search Results 971-980 of 17105 for Antagonist
Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.
Levels will be checked at baseline and also at day +4 post intervention. Patients taking H2-antagonists or proton pump inhibitors; Patients on therapeutic ...
About this study. The goal of this study is to provide access to axicabtagene ciloleucel for patients diagnosed with a disease approved for treatment with ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The primary objective of this study is to determine the safety and tolerability of utilizing the insulin-like growth factor-1-methotrexate ...
Patients must have a one-week washout period from prior hormonal therapy (e.g., testosterone, estrogen, progestin, gonadotropin-releasing hormone antagonist).
Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With ...
Other enteropathies will also be included: collagenous sprue, idiopathic sprue, lymphocytic enterocolitis, idiopathic enteropathies, collagenous gastritis, ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!